SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical review: how to optimize management of high-risk surgical patients.

Pearse, RM; Rhodes, A; Grounds, RM (2004) Clinical review: how to optimize management of high-risk surgical patients. Crit Care, 8 (6). pp. 503-507. ISSN 1466-609X https://doi.org/10.1186/cc2922
SGUL Authors: Rhodes, Andrew

[img]
Preview
PDF Published Version
Available under License ["licenses_description_publisher" not defined].

Download (56kB) | Preview

Abstract

For many patients optimal perioperative care may require little or no additional medical management beyond that given by the anaesthetist and surgeon. However, the continued existence of a group of surgical patients at high risk for morbidity and mortality indicates an ongoing need to identify such patients and deliver optimal care throughout the perioperative period. A group of patients exists in whom the risk for death and serious complications after major surgery is in excess of 20%. The risk is related mainly to the patient's preoperative physiological condition and, in particular, the cardiovascular and respiratory reserves. Cardiovascular management of the high-risk surgical patient is of particular importance. Once the medical management of underlying disease has been optimized, two principal areas remain: the use of haemodynamic goals to guide fluid and inotropic therapy, and perioperative beta blockade. A number of studies have shown that the use of goal-directed haemodynamic therapy during the perioperative period can result in large reductions in morbidity and mortality. Some patients may also benefit from perioperative beta blockade, which in selected patients has also been shown to result in significant mortality reductions. In this review a pragmatic approach to perioperative management is described, giving guidance on the identification of the high-risk patient and on the use of goal-directed haemodynamic therapy and beta blockade.

Item Type: Article
Additional Information: © BioMed Central Ltd 2004
Keywords: Adrenergic beta-Antagonists, Cardiovascular Physiological Phenomena, Chemoprevention, Evidence-Based Medicine, Fluid Therapy, Humans, Monitoring, Physiologic, Myocardial Ischemia, Perioperative Care, Postoperative Complications, Quality Assurance, Health Care, Risk Assessment, Risk Factors, Humans, Myocardial Ischemia, Postoperative Complications, Adrenergic beta-Antagonists, Monitoring, Physiologic, Chemoprevention, Fluid Therapy, Perioperative Care, Risk Assessment, Risk Factors, Evidence-Based Medicine, Quality Assurance, Health Care, Cardiovascular Physiological Phenomena, Emergency & Critical Care Medicine, 11 Medical And Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Crit Care
ISSN: 1466-609X
Language: eng
Dates:
DateEvent
December 2004Published
6 August 2004Published Online
Publisher License: Publisher's own licence
PubMed ID: 15566623
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/107548
Publisher's version: https://doi.org/10.1186/cc2922

Actions (login required)

Edit Item Edit Item